Henry Schein, Inc. (NASDAQ:HSIC) – Equities researchers at Northcoast Research raised their Q2 2017 earnings estimates for shares of Henry Schein in a report issued on Monday. Northcoast Research analyst E. Snyder now forecasts that the company will post earnings per share of $1.77 for the quarter, up from their previous forecast of $1.74. Northcoast Research has a “Buy” rating and a $218.00 price target on the stock. Northcoast Research also issued estimates for Henry Schein’s Q3 2017 earnings at $1.85 EPS, Q4 2017 earnings at $1.99 EPS, FY2017 earnings at $7.38 EPS, Q1 2018 earnings at $2.01 EPS, Q2 2018 earnings at $2.00 EPS and FY2018 earnings at $8.22 EPS.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 9th. The company reported $1.76 EPS for the quarter, beating the Zacks’ consensus estimate of $1.65 by $0.11. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The firm had revenue of $2.92 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same period last year, the firm earned $1.41 EPS. The company’s quarterly revenue was up 7.7% on a year-over-year basis.

TRADEMARK VIOLATION NOTICE: This article was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/08/08/q2-2017-eps-estimates-for-henry-schein-inc-raised-by-northcoast-research-hsic.html.

Several other research analysts have also recently issued reports on the stock. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Friday, June 23rd. Craig Hallum initiated coverage on shares of Henry Schein in a report on Tuesday, April 11th. They set a “hold” rating for the company. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. Finally, Piper Jaffray Companies initiated coverage on shares of Henry Schein in a report on Monday, June 12th. They set a “neutral” rating and a $200.00 price target for the company. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $185.56.

Shares of Henry Schein (NASDAQ HSIC) opened at 183.79 on Tuesday. The firm has a market capitalization of $14.58 billion, a PE ratio of 27.93 and a beta of 1.09. Henry Schein has a 52-week low of $146.23 and a 52-week high of $186.99. The stock’s 50 day moving average price is $183.44 and its 200-day moving average price is $174.47.

A number of hedge funds and other institutional investors have recently modified their holdings of HSIC. BlackRock Inc. raised its position in shares of Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after buying an additional 5,414,761 shares during the last quarter. MARSHALL WACE ASIA Ltd bought a new position in shares of Henry Schein during the first quarter valued at $50,281,000. Marshall Wace North America L.P. bought a new position in shares of Henry Schein during the first quarter valued at $50,281,000. PGGM Investments bought a new position in shares of Henry Schein during the second quarter valued at $32,623,000. Finally, JPMorgan Chase & Co. raised its position in shares of Henry Schein by 12.4% in the first quarter. JPMorgan Chase & Co. now owns 1,515,861 shares of the company’s stock valued at $257,650,000 after buying an additional 167,213 shares during the last quarter. Institutional investors own 90.87% of the company’s stock.

In other Henry Schein news, EVP Gerald A. Benjamin sold 12,578 shares of the company’s stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the transaction, the executive vice president now directly owns 44,061 shares in the company, valued at $7,715,081.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.27% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.